Welcome to Lavipharm

Lavipharm is a dynamic, international healthcare company driven by creativity and innovation, always striving to provide access to improved healthcare solutions.

Research & Innovation



Patnering with Lavipharm


Pharmacy Network



Driven by our vision to improve quality of life, at Lavipharm, we are applying innovative ideas in every field of our commercial activity. With the objective to assist in essence healthcare professionals in their daily practice, we aim to provide them with reliable, safe and innovative treatment options.

Lavipharm is active in the field of pharmaceutical, OTC and dermocosmetic products as well as the provision of specially designed services to pharmacies. We offer a portfolio of effective, safe and clinically tested products focusing mainly in the areas of cardiology, neurology (CNS), urology, oncology and chronic pain.

Investor Relations

In this section, you may find all public information for Lavipharm SA, the mother company of the Lavipharm Group, listed on the Athens Stock Exchange since 1995, such as  Historical Share Prices, Share Capital History and Major Shareholders List.

Pharma PLUS

Pharma PLUS, a member of the Lavipharm Group, is an innovative company focusing in the provision of specially designed services to the pharmacists, working closely with him in the development and transformation of the Greek pharmacy in a modern, sophisticated business unit.

Pharma PLUS, since its operation, has established today a nationwide pharmacy network, aiming at the competitiveness of each member pharmacy separately and at large, against alternative distribution channels and pharmacy chains.


CASTALIA products have been marketed in Greece since 1992 and today are sold in 16 countries internationally. They have been developed in the Lavipharm research laboratories, following international quality standards and are clinically tested.

With more than 20 years of Expertise in Skin Biology, CASTALIA is focused on Health, dedicated to Beauty and Backed by Science.